ENANTA PHARMACEUTICALS, INC Debt Securities, Available-for-sale, Noncurrent
ENANTA PHARMACEUTICALS, INC (ENTA) had Debt Securities, Available-for-sale, Noncurrent of $42.51 million as of 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2024-08-07
- 2024-06-30: Debt Securities, Available-for-sale, Noncurrent $42.51M.
- 2023-09-30: Debt Securities, Available-for-sale, Noncurrent $0.00.
- 2023-06-30: Debt Securities, Available-for-sale, Noncurrent $5.92M.
- 2023-03-31: Debt Securities, Available-for-sale, Noncurrent $15.04M.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2024-06-30 | $42.51M 10-Q · filed 2024-08-07 |
| 2023-09-30 | $0.00 10-Q · filed 2024-08-07 |
| 2023-06-30 | $5.92M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $15.04M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $26.94M 10-Q · filed 2023-02-08 |
| 2022-09-30 | $29.29M 10-K · filed 2023-11-22 |
| 2022-06-30 | $39.43M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $42.22M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $88.67M 10-Q · filed 2022-02-10 |
| 2021-09-30 | $108.42M 10-K · filed 2022-11-23 |
| 2021-06-30 | $115.71M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $24.49M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $18.46M 10-Q · filed 2021-02-09 |
| 2020-09-30 | $32.63M 10-K · filed 2021-11-24 |
| 2020-06-30 | $65.40M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $80.10M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $40.94M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $65.01M 10-K · filed 2020-11-25 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-09 |
| 2019-03-31 | $16.51M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $11.46M 10-Q · filed 2019-02-08 |
| 2018-09-30 | $16.39M 10-K · filed 2019-11-27 |
| 2017-09-30 | $70.04M 10-K · filed 2018-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |